pancrelipase Creon
Selected indexed studies
- CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency. (Adv Ther, 2010) [PMID:21086085]
- Pancrelipase. (, 2006) [PMID:32352703]
- Pancrelipase Therapy. (, 2026) [PMID:30521237]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency. (2010) pubmed
- Pancrelipase. (2006) pubmed
- Pancrelipase Therapy. (2026) pubmed
- Pancrelipase for pancreatic disorders: An update. (2010) pubmed
- Pancreatic enzymes (pancrelipase). (2020) pubmed
- Pancrelipase(Archived). (2026) pubmed
- Pancreatic enzyme pharmacotherapy. (2007) pubmed
- Administration of CREON® pancrelipase pellets via gastrostomy tube is feasible with no loss of gastric resistance or lipase activity: an in vitro study. (2011) pubmed
- Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial. (2010) pubmed
- A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery. (2011) pubmed